NRx Pharmaceuticals (NRXP) Reports In-Line Q1 EPS

NRx Pharmaceuticals (NASDAQ: NRXP) reported Q1 EPS of $0.00. Revenue for the quarter came in at $1.07 million.

For earnings history and earnings-related data on NRx Pharmaceuticals (NRXP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery